Cofactor Genomics
San Francisco
About Cofactor Genomics
Cofactor Genomics is a company focused on predictive immune modeling. They aim to advance precision medicine by overcoming existing barriers. Cofactor facilitates the shift from single-analyte biomarkers to more comprehensive multidimensional biomarkers using health expression models. Their capabilities include molecular, informatic, and database tools, with one of the first CAP-certified clinical RNA sequencing laboratories. This certification helps their partners conduct clinical trials more efficiently and cost-effectively. Their expertise in molecular biology, informatics, and database management enables them to provide high-quality services to the healthcare and pharmaceutical sectors, contributing to medical research and improving patient outcomes.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $10K – $50K
- Total funding: $29.0M
- Last round: Series Unknown (Dec 2025)
- Website: cofactorgenomics.com
- Phone: (314) 531-4647
Industries & Categories
Biotechnology, Clinical Trials, Genetics, Health Care, Health Diagnostics
Social Profiles
Canonical: https://fsome.com/organization/cofactor-genomics-57080 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.